DM
Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ
10.14
0.00 (0.00%)
Real-time Data
01:30 PM
Day's Range
10.1410.14
52 wk Range
9.8610.20
Financial Statements - DMII - Drugs Made In America Acquisition II Corp.
Revenue
0
Net Income
4.18M
EBITDA
-1.85M
Free Cash Flow
-1.01M
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 0 |
| Cost of Goods | - |
| Gross Profit | - |
 Operating Expense | - |
| Operating Income | -1.30M |
| Non-Operating Interest | - |
| Other Income Expense | 553.74K |
| Pre Tax Income | 4.18M |
| Income Tax | - |
| Net Income | 4.18M |
| EPS Basic | 0.16 |
| EPS Diluted | 0.15 |
| Basic Shares Outstanding | 26.10M |
| Diluted Shares Outstanding | 26.10M |
| Ebit | -1.30M |
| Ebitda | -1.85M |
| Net Income Continuous Operations | 4.18M |
| Minority Interests | - |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
